M., Morsink, L
SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda
Furthermore, since the GLP-1 receptors are trafficked and inserted into the axon terminal membranes, that may make it difficult to visualize binding, because one is looking at diffuse scattered axon terminals rather than concentrated neuronal cell body labeling
In practice, all too often nutrition and lifestyle are an afterthoughtor even ignored
H., Finan, B., & Tena-Sempere, M
We have them on the heart and the sinus node